Details for New Drug Application (NDA): 077131
✉ Email this page to a colleague
The generic ingredient in RIVASTIGMINE TARTRATE is rivastigmine tartrate. There are thirty-two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the rivastigmine tartrate profile page.
Summary for 077131
Tradename: | RIVASTIGMINE TARTRATE |
Applicant: | Sun Pharm |
Ingredient: | rivastigmine tartrate |
Patents: | 0 |
Pharmacology for NDA: 077131
Mechanism of Action | Cholinesterase Inhibitors |
Suppliers and Packaging for NDA: 077131
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RIVASTIGMINE TARTRATE | rivastigmine tartrate | CAPSULE;ORAL | 077131 | ANDA | Sun Pharmaceutical Industries, Inc. | 62756-145 | 62756-145-13 | 500 CAPSULE in 1 BOTTLE (62756-145-13) |
RIVASTIGMINE TARTRATE | rivastigmine tartrate | CAPSULE;ORAL | 077131 | ANDA | Sun Pharmaceutical Industries, Inc. | 62756-145 | 62756-145-61 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (62756-145-61) / 1 CAPSULE in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 1.5MG BASE | ||||
Approval Date: | Oct 22, 2007 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 3MG BASE | ||||
Approval Date: | Oct 22, 2007 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 4.5MG BASE | ||||
Approval Date: | Oct 22, 2007 | TE: | AB | RLD: | No |
Complete Access Available with Subscription